Literature DB >> 2823469

Studies on the recombination between RNA genomes of poliovirus: the primary structure and nonrandom distribution of crossover regions in the genomes of intertypic poliovirus recombinants.

E A Tolskaya1, L I Romanova, V M Blinov, E G Viktorova, A N Sinyakov, M S Kolesnikova, V I Agol.   

Abstract

A series of intertypic (type 3/type 1) poliovirus recombinants was obtained whose crossover sites were expected to be located in the middle of the viral genome, between the loci encoding type-specific antigenic properties, on the 5' side, and an altered sensitivity to guanidine, on the 3' side. The primary structures of the crossover regions in the genomes of these recombinants were determined by the primer extension method. The length of the crossover sites (the uninterrupted sequences shared by the recombinant and both parental genomes that are flanked, in the recombinant RNAs, by two heterotypic segments) varied between 2 and 32 nucleotides, but the majority of the sites were 5 nucleotides long or shorter. The crossover sites were nonrandomly distributed over the presumably available genome region: only a single such site was found within the gene for polypeptide 2A, whereas an apparent clustering of the crossover sites was encountered in other genomic segments. When the crossover sites were superimposed on a model of the secondary structure of the relevant region of the viral RNA molecule, a pattern consistent with the previously proposed mechanism of poliovirus recombination (L.I. Romanova, V.M. Blinov, E.A. Tolskaya, E.G. Viktorova, M.S. Kolesnikova, E.I. Guseva, and V.I. Agol (1986) Virology 155, 202-213) was observed. It is suggested that the nonrandom distribution of the crossover sites in the genomes of intertypic poliovirus recombinants was due to two factors: the existence of preferred sites for recombination, and selection against recombinants with a lowered level of viability.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823469     DOI: 10.1016/0042-6822(87)90170-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  49 in total

1.  A human rotavirus with rearranged genes 7 and 11 encodes a modified NSP3 protein and suggests an additional mechanism for gene rearrangement.

Authors:  E Gault; N Schnepf; D Poncet; A Servant; S Teran; A Garbarg-Chenon
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  RNA recombination in brome mosaic virus: effects of strand-specific stem-loop inserts.

Authors:  R C L Olsthoorn; A Bruyere; A Dzianott; J J Bujarski
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure.

Authors:  C L Rowe; J O Fleming; M J Nathan; J Y Sgro; A C Palmenberg; S C Baker
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Recombination of poliovirus RNA proceeds in mixed replication complexes originating from distinct replication start sites.

Authors:  Denise Egger; Kurt Bienz
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  Genetic recombination in brome mosaic virus: effect of sequence and replication of RNA on accumulation of recombinants.

Authors:  P D Nagy; J J Bujarski
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

6.  Nonreplicative homologous RNA recombination: promiscuous joining of RNA pieces?

Authors:  Anatoly P Gmyl; Sergey A Korshenko; Evegny V Belousov; Elena V Khitrina; Vadim I Agol
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

Review 7.  RNA recombination in animal and plant viruses.

Authors:  M M Lai
Journal:  Microbiol Rev       Date:  1992-03

8.  Coronaviruses as vectors: stability of foreign gene expression.

Authors:  Cornelis A M de Haan; Bert Jan Haijema; David Boss; Frank W H Heuts; Peter J M Rottier
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

9.  A model for rearrangements in RNA genomes.

Authors:  E V Pilipenko; A P Gmyl; V I Agol
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

10.  Selection of an attenuated Coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen.

Authors:  N Van Houten; P E Bouchard; A Moraska; S A Huber
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.